{"schema_version":"1","generated_at":"2026-11-08T01:41:21.509Z","data_as_of":null,"url":"https://www.findmykol.com/kol/earle-burgess","json_url":"https://www.findmykol.com/kol/earle-burgess/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"earle-burgess","name":"Earle Burgess","credential":"MD","specialty":"Hematology","specialty_raw":"Hematology","therapeutic_area":"Hematology","therapeutic_areas":["Hematology"],"institution":"Levine Cancer Institute","institution_url":"https://www.findmykol.com/institution/levine-cancer-institute","city":"Charlotte","state":"NC","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1194872044","orcid":"0000-0003-4293-4680","openalex":"A5018148854"},"summary":"Earle Burgess is a Hematology physician affiliated with Levine Cancer Institute. OpenAlex indexes 110 publications with 3,768 citations (h-index 22); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Hematology"]},"scholarship":{"works_count":110,"cited_by_count":3768,"h_index":22,"latest_activity_year":2025,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT03246347","title":"A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate Cancer","phase":"PHASE2","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"Wake Forest University Health Sciences","source_url":"https://clinicaltrials.gov/study/NCT03246347","trial_url":"https://www.findmykol.com/trial/NCT03246347"},{"nct":"NCT02612194","title":"LCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"Wake Forest University Health Sciences","source_url":"https://clinicaltrials.gov/study/NCT02612194","trial_url":"https://www.findmykol.com/trial/NCT02612194"}],"source":"trials"},"payments":{"company_count":10,"program_years":{"first":2021,"last":null},"rows_total":41,"shown":3,"withheld":38,"rows":[{"payer":"Regeneron","program_year":2025,"amount_usd":119414.65,"payment_count":37,"source_url":"https://openpaymentsdata.cms.gov/search?query=1194872044"},{"payer":"Seagen","program_year":2025,"amount_usd":49765,"payment_count":6,"source_url":"https://openpaymentsdata.cms.gov/search?query=1194872044"},{"payer":"Pfizer","program_year":2025,"amount_usd":40208.16,"payment_count":11,"source_url":"https://openpaymentsdata.cms.gov/search?query=1194872044"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1194872044","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Study EV-103 cohort H: Neoadjuvant treatment with enfortumab vedotin (EV) monotherapy in cisplatin (cis)-ineligible patients (pts) with muscle invasive bladder cancer (MIBC)—3-year efficacy results.","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.4583","status":"verified"},{"title":"Molecular analysis of primary and metastatic sites in patients with renal cell carcinoma","year":2024,"journal":"Journal of Clinical Investigation","source_url":"https://doi.org/10.1172/jci176230","status":"verified"},{"title":"Renal cell carcinoma histologic subtypes exhibit distinct transcriptional profiles","year":2024,"journal":"Journal of Clinical Investigation","source_url":"https://doi.org/10.1172/jci178915","status":"verified"},{"title":"Study EV-103: Neoadjuvant treatment with enfortumab vedotin monotherapy in cisplatin-ineligible patients with muscle invasive bladder cancer (MIBC)—2-year event-free survival and safety data for Cohort H.","year":2024,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.4564","status":"verified"},{"title":"Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma","year":2023,"journal":"New England Journal of Medicine","source_url":"https://doi.org/10.1056/nejmoa2308849","status":"verified"}],"source":"works"},"contact":{"address_1":"10660 PARK RD","address_2":"STE 2100","city":"Charlotte","state":"NC","zip":"282108413","phone":"980-442-0410","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1194872044","source":"identity"},"similar":[{"name":"Peter Voorhees","slug":"peter-voorhees","institution":"Levine Cancer Institute","specialty":"Hematology","url":"https://www.findmykol.com/kol/peter-voorhees","json_url":"https://www.findmykol.com/kol/peter-voorhees/profile.json"},{"name":"Benjamin Moeller","slug":"benjamin-moeller","institution":"Levine Cancer Institute","specialty":"Radiation Oncology","url":"https://www.findmykol.com/kol/benjamin-moeller","json_url":"https://www.findmykol.com/kol/benjamin-moeller/profile.json"},{"name":"Jubilee Brown","slug":"jubilee-brown","institution":"Levine Cancer Institute","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/jubilee-brown","json_url":"https://www.findmykol.com/kol/jubilee-brown/profile.json"},{"name":"Robert Naumann","slug":"robert-naumann","institution":"Levine Cancer Institute","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/robert-naumann","json_url":"https://www.findmykol.com/kol/robert-naumann/profile.json"},{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Scott Kaufmann","slug":"scott-kaufmann","institution":"Mayo Clinic College of Medicine","specialty":"Hematology","url":"https://www.findmykol.com/kol/scott-kaufmann","json_url":"https://www.findmykol.com/kol/scott-kaufmann/profile.json"},{"name":"Ruben Mesa","slug":"ruben-mesa","institution":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/ruben-mesa","json_url":"https://www.findmykol.com/kol/ruben-mesa/profile.json"},{"name":"Jaroslaw Maciejewski","slug":"jaroslaw-maciejewski","institution":"Cleveland Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/jaroslaw-maciejewski","json_url":"https://www.findmykol.com/kol/jaroslaw-maciejewski/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":38,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2024-07-15","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}